+86-0635-6175299

Company Details

Shandong Haohong Biotechnology Co., Ltd.

[Shandong,China]

Business Type:Manufacturer

Main Markets: Americas , Asia , East Europe , Europe , Middle East , North Europe , West Europe , Worldwide

Exporter:71% - 80%

Certs:Test Report, ISO9001
Language

Shandong Haohong Biotechnology Co., Ltd.

 HomeNewsSupply of high-quality Alectinib API and Intermediates

Supply of high-quality Alectinib API and Intermediates

2021-08-19

What is Alectinib?

Alectinib is used to treat a certain type of non-small-cell lung cancer (NSCLC) that has spread to other parts of the body. Alectinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.

Shandong Haohong Biotechnology Co., Ltd is mainly focuses on the development of anti-cancer, anti-diabets series of API and its advanced intermediates. The main products include Bicalutamide, enzalutamide, apalutamide, macitentan, cabozantinib, ceritinib, empagliflozin, tofacitinib citrate, and alectinib,etc. In line with the concept of "truth-seeking, innovation and integrity", we had exported our products to the United States, European countries, Japan, India, Bangladesh and other overseas markets. At present, Our company has dozens of advanced intermediates, all of which are commercialized.Alectinib is our top strong project.

Our Alectinib intermediate list is as following, we have all the below intermedites offering all year.

Alectinib

Alectinib-1 Alectinib-2

If you want to know more information about our company and products, please visit our website at http://www.haohongpharma.com. We will offer the best price and the best quality for you.

Previous: Supply of high-quality Ceritinib API and Intermediates

Next: Forxiga approved in the EU for the treatment of chronic kidney disease in patients with and without type-2 diabetes

 HomeNewsSupply of high-quality Alectinib API and Intermediates

Shandong Haohong Biotechnology Co., Ltd.